LRMR
Larimar Therapeutics, Inc.NASDAQHealthcare$4.79+5.43%ClosedMarket Cap: $409.9M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
8
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Mar 02 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | Buy | 1,084,012 | $5.00 | 10,622,957 |
| Mon Mar 02 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | Buy | 1,084,010 | $5.00 | 10,622,928 |
| Mon Mar 02 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | Buy | 831,978 | $5.00 | 8,153,107 |
| Mon Mar 02 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | Buy | 2,000,000 | $5.00 | 6,207,982 |
| Mon Mar 02 | Hamilton Thomas Edward | director | Buy | 100,000 | $5.00 | 664,798 |
| Mon Mar 02 | THOMAS FRANK E | director | Buy | 5,000 | $5.00 | 7,000 |
| Mon Mar 02 | SHERMAN JEFFREY W | director | Buy | 5,000 | $5.00 | 5,000 |
| Tue Jan 27 | Shankar Gopi | officer: Chief Development Officer | Sell | 153,822 | $3.60 | 153,822 |
| Tue Jan 27 | Shankar Gopi | officer: Chief Development Officer | Sell | 25,637 | $0.00 | 76,443 |
| Tue Jan 27 | Clayton Russell | officer: Chief Medical Officer | Sell | 153,822 | $3.60 | 153,822 |